Text Resize

-A +A
Bookmark and Share

AstraZeneca to Pay $520 Million to Settle Claims of Off-Label Drug Marketing

Tuesday, May 4, 2010

AstraZeneca to Pay $520 Million to Settle Claims of Off-Label Drug Marketing

View testimony as a [PDF].